LATE-BREAKING ABSTRACT: Protective effects of surfactant protein D (SP-D) treatment in 1,3-ß-glucan-modulated allergic inflammation
Dalia Fakih (Odense, Denmark), Dalia Fakih, Bartosz Pilecki, Anders Schlosser, Christine Jepsen, Laura Thomsen, Jens Madsen, Howard Clark, Kenneth Barfod, Soren Hansen, Niels Marcussen, Rania Jounblat, Soulaima Chamat, Uffe Holmskov, Grith Sorensen
|  |
LATE-BREAKING ABSTRACT: T-cell membrane organization as a potential new target in asthma
Gilles Dufour (Wanze, Belgium), Gilles Dufour, Natacha Rocks, Audrey Duyckaerts, Catherine Gerard, Andreia Giro dos Santos, Fabienne Perin, Marie-Paule Mingeot-Leclercq, Brigitte Evrard, Didier Cataldo
| |
LATE-BREAKING ABSTRACT: Aspergillus fumigatus specific IgE, but not total IgE or A. fumigatus specific IgG is associated with evidence of lung damage in asthma
Kerry Woolnough (Lichfield, United Kingdom), Kerry Woolnough, Catherine Pashley, Andrew Wardlaw
|  |
LATE-BREAKING ABSTRACT: IgE sensitisation to A. fumigatus is associated with fixed airflow obstruction independent of atopic status
Kerry Woolnough (Lichfield, United Kingdom), Kerry Woolnough, Catherine Pashley, Andrew Wardlaw
| |
LATE-BREAKING ABSTRACT: Prevention of COPD exacerbation by lysozyme: A double-blind, randomized, placebo-controlled study
Masakazu Ichinose (Sendai, Japan), Masakazu Ichinose, Yoshinosuke Fukuchi, Koichiro Tatsumi, Hiromasa Inoue, Toshihisa Arai, Kai Shibata, Hideaki Miyagishi, Yukinori Sakata
| |
LATE-BREAKING ABSTRACT: miR-877 and its target protein HDAC6 are involved in airway inflammation
Yongyao Cui (Shanghai, China), Haozhong Lu, Jianrong Xu, Zhihua Yu, Juan Li, Yu Qiu, Wenhui Zhang, Yongyao Cui
| |
LATE-BREAKING ABSTRACT: Safety, pharmacokinetic and pharmacodynamic profile of RV1162, a narrow spectrum kinase inhibitor, in healthy subjects and COPD patients
Paul Russell (London, United Kingdom), Paul Russell, Chris Stevenson, Catherine Charron, Charlie Brindley, Dave Singh
| |
LATE-BREAKING ABSTRACT: Tiotropium efficacy and exacerbation risk in patients with different blood eosinophil levels
Peter M.A. Calverley (Liverpool, United Kingdom), Peter Calverley, Christoph Hallmann, Norbert Metzdorf, Lars Grnke, Achim Mueller, David Halpin
| |
LATE-BREAKING ABSTRACT: PT003, a novel co-suspension MDI glycopyrronium/formoterol fixed-dose combination is superior to monocomponents in patients with COPD
Klaus Friedrich Rabe (Grosshansdorf, Germany), Klaus Rabe, Fernando Martinez, Roberto Rodriguez-Roisin, Leonardo M. Fabbri, Gary T. Ferguson, Paul Jones, Stephen Rennard, Michael Golden, Patrick Darken, Chad Orevillo, Tracy Fischer, Colin Reisner
| |
LATE-BREAKING ABSTRACT: Serum IL-13 is a peripheral biomarker for Type 2 asthma
Fang Cai (South San Francisco, United States of America), Fang Cai, David F. Choy, Jochen Brumm, Cecile Holweg, Alyssa Morimoto, Joseph R. Arron, John Matthews, Heleen Scheerens
| |
LATE-BREAKING ABSTRACT: A Phase 1b study of PUR0200, a novel tiotropium formulation, in COPD patients
David Hava (Lexington, United States of America), David Hava, Katie Kane, Fred Reid, Arjun Ravi, Jo Collier, Tess Schmalbach, Dave Singh
| |
LATE-BREAKING ABSTRACT: ENERGITO: Efficacy and safety of once-daily combined tiotropium + olodaterol versus twice-daily combined fluticasone propionate + salmeterol
Kai Michael Beeh (Wiesbaden, Germany), Kai-Michael Beeh, Eric Derom, Jose Echave-Sustaeta, Lars Groenke, Alan Hamilton, Dongmei Zhai, Leif Bjermer
| |
LATE-BREAKING ABSTRACT: Novel inhaled ROR/c inhibitor for potential treatment of COPD
Srinivasa Honnegowda (Navi Mumbai, India), Srinivasa Honnegowda, Abraham Thomas, Sachin Chaudhari, Sanjib Das, Daisy Shah, Malini Bajpai, Indrani Sarkar, Abhay Kulkarni, Girish Gudi, Satyawan Jadhav, Neelima Khairatkar-Joshi
| |
LATE-BREAKING ABSTRACT: Morin attenuates ovalbumin-induced airway inflammation by modulating oxidative stress-responsive MAPK signaling
Xiaoning Zeng (Nanjing, China), Xiaoning Zeng, Yuan Ma, Mao Huang
| |
LATE-BREAKING ABSTRACT: Interleukin-33 augments rhinovirus-induced type 2 immune responses in people with asthma, but not in healthy donors
John Upham (Brisbane, Australia), John Upham, Megan Landgraf, Camilla Xi
| |
LATE-BREAKING ABSTRACT: The effects of NKT cells on the different degrees of severity bronchial asthma in mice
Chuangli Hao (Suzhou, China), Fanfan Chi, Chuangli Hao
| |
LATE-BREAKING ABSTRACT: Triptolide modulates the CD4+ T cells balance in an allergic asthmatic mouse model
Ningfei Ji (Nanjing, China), Ningfei Ji, Wenjing Wang, Mingshun Zhang, Mao Huang
| |
LATE-BREAKING ABSTRACT: The role of IL-17A in the pathogenesis of early infection with RSV increasing susceptibility to asthma
Zhijun Jie (Shanghai, China), Yanchao He, Wei Sun, Jindong Shi, Xiao Su, Zhijun Jie
| |
LATE-BREAKING ABSTRACT: The study of fibulin-1 as a novel biomarker in bronchial asthma and its association to disease severity
Abeer Kassem (Alexandria, Egypt), Dalal El Giziry, Nermin Zakaria, Abeer Kassem, Mona Abdellatif
| |
LATE-BREAKING ABSTRACT: Inhibition of MAP3K19 - A novel therapeutic approach for treatment of IPF
Stefen Boehme (San Diego, United States of America), Stefen Boehme, Tai Wei Ly, Kevin Bacon
| |